Antifibrotic therapy by sustained release of low molecular weight heparin from poly(lactic-co-glycolic acid) microparticles on bleomycin-induced pulmonary fibrosis in mice
Crossref DOI link: https://doi.org/10.1038/s41598-020-76034-0
Published Online: 2020-11-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Saito, Takashi
Kotani, Takuya
Suzuki, Koichi
Text and Data Mining valid from 2020-11-04
Version of Record valid from 2020-11-04
Article History
Received: 3 July 2019
Accepted: 20 October 2020
First Online: 4 November 2020
Competing interests
: The authors declare no competing interests.